However, in participants who had diabetes mellitus pre-operatively, SG promoted a greater change, on average, of 27.98 mg/dL in IgM levels than those who did not have diabetes, p<0.05 (Table 5). The gene discussed is CD40LG; the disease is diabetes mellitus.